Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) FCF Margin: 2009-2025

Historic FCF Margin for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to 1.97%.

  • Cumberland Pharmaceuticals' FCF Margin fell 309.00% to 1.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.31%, marking a year-over-year increase of 2063.00%. This contributed to the annual value of -1.79% for FY2024, which is 1649.00% down from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' FCF Margin is 1.97%, which was down 73.87% from 7.54% recorded in Q2 2025.
  • Cumberland Pharmaceuticals' FCF Margin's 5-year high stood at 47.42% during Q2 2023, with a 5-year trough of -25.63% in Q1 2024.
  • Over the past 3 years, Cumberland Pharmaceuticals' median FCF Margin value was 7.54% (recorded in 2025), while the average stood at 7.68%.
  • In the last 5 years, Cumberland Pharmaceuticals' FCF Margin slumped by 5,618bps in 2024 and then soared by 5,851bps in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' FCF Margin (Quarterly) stood at 23.45% in 2021, then surged by 1,811bps to 41.56% in 2022, then crashed by 3,096bps to 10.60% in 2023, then surged by 763bps to 18.23% in 2024, then slumped by 309bps to 1.97% in 2025.
  • Its FCF Margin stands at 1.97% for Q3 2025, versus 7.54% for Q2 2025 and 32.88% for Q1 2025.